Astec LifeSciences MD Ashok Hiremath sells stock worth ₹165 million
The stock has rallied on the back of strong earnings growth and overall optimism for pharma sector
Shailaja Mohapatra - August 13, 2020
The Godrej guardian
The legacy has thrived for 116 years. Its chairman thinks the Godrej group is even better poised for the future
Meenakshi Radhakrishnan-Swami - June 24, 2015